Trials / Completed
CompletedNCT05907772
Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma
Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma: A Multi-center Retrospective Cohort Study in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 522 (actual)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center study in China to investigate the role of PIVKA-II in HCC recipient selection and prognostic stratification by analyzing the data of 522 recipients with HCC registered in the China Liver Transplant Registry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2022-08-27
- Primary completion
- 2022-10-25
- Completion
- 2022-11-10
- First posted
- 2023-06-18
- Last updated
- 2023-06-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05907772. Inclusion in this directory is not an endorsement.